Perfil
Allen Hodge worked as a Sales Director at Shire ViroPharma, Inc. from 2012 to 2015 and as a Vice President & General Manager at BioCryst Pharmaceuticals, Inc. from 2020 to 2022.
He graduated from Boston University with a graduate degree and from Arkansas Tech University with an undergraduate degree.
Antiguos cargos conocidos de Allen Hodge.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2022 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Sales & Marketing | 01/01/2015 |
Formación de Allen Hodge.
| Boston University | Graduate Degree |
| Arkansas Tech University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Allen Hodge
